[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@GeneInvesting](/creator/twitter/GeneInvesting) "And lets remember Intellias Class I/II would literally be off this graph Comparing $ALNY to $NTLA at 12m is like comparing prime Lebron James to Bronny. Heres the best part: XXXX% of Alnylam patients were Class I/II and they still had worsening of XX% on average at XX months. Intellias Class I/II π° XXXX (3% improvement) And Intellia had one Class X who was variant and baseline 19600+ (the other companies had 8500 max). They died at Day XXX so its likely the XXXX wouldve been even better without them" [X Link](https://x.com/GeneInvesting/status/1978114478387659202) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-14T15:03Z 14.5K followers, 4877 engagements "1 wasnt enough doctors say: lets cure X this time πͺ $BEAM $PRME $NTLA $CRSP The Gene Editing revolution has BEGUN" [X Link](https://x.com/GeneInvesting/status/1978828308277035485) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-16T14:20Z 14.5K followers, 8637 engagements "@3primeAnalytica He sold recently so he supposedly doesnt own it anymore. His new baby is $BBIO which is a direct competitor so thats why he shits on $NTLA. Its just remarkable how much misinformation I find from him" [X Link](https://x.com/GeneInvesting/status/1965236929907286130) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-09T02:12Z 14.5K followers, XXX engagements "$PFE alone made $XXX billion last year in ATTR-CM. They made $XXX billion in the first half of 2025. So even if that just stays equal and doesnt grow theyll be at $XXX billion this year plus the 1400 patients $ALNY treated in their first XX days plus the strong $BBIO start. Likely $X billion this year" [X Link](https://x.com/GeneInvesting/status/1966553133481677102) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-12T17:22Z 14.5K followers, XXX engagements "4) Grok expert mode also selected $NTLA over $BBIO and $ALNY β ChatGPT first tried to use 36/42 month ALNY data to compare so that had to be corrected. Grok for some reason couldnt find NTLAs KCCQ value at first and was using inaccurate nt-probnp values for bbio and alny" [X Link](https://x.com/GeneInvesting/status/1966660154449162626) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-13T00:28Z 14.5K followers, 1528 engagements "This is beautiful I think tears of pride came to my eyes π₯Ήπ $NTLA" [X Link](https://x.com/GeneInvesting/status/1968146620719173991) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-17T02:54Z 14.5K followers, 5800 engagements "@RandomBioThinks @SnackBioTech Definitely not the same. $BBIO will not equal $NTLA or gen X $ALNY in future" [X Link](https://x.com/GeneInvesting/status/1968147188007199206) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-17T02:57Z 14.5K followers, XXX engagements "@zhaoweiasu @ArkadiBaudelair We do know. Weve studied it for well over XX years" [X Link](https://x.com/GeneInvesting/status/1969015475918233801) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-19T12:27Z 14.5K followers, XXX engagements "Im XX% certain that these analysts are counting Gen X as Amvuttra too because there is ZERO chance Amvuttra EVER makes $9.2B in a year. $ALNY $NTLA I can see their Gen X (Nucresiran) making that though. In X weeks Intellia will essentially show that doctors will morally be unable to prescribe Amvuttra (once Nex Z is available). Ex: Do you want to worsen by XX% in your first year or not And Alnylam got their data with the healthiest group of patients by far (Hurt them on curves but helped them on majority of other things)" [X Link](https://x.com/GeneInvesting/status/1969207429281038771) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-20T01:10Z 14.5K followers, 6905 engagements "1/π§΅Why Nex Z is dramatically better than Vutrisiran $NTLA $ALNY $BBIO Nex Z: Day 28: -XX% (18.9 g/mL remained) XX month: -XXXX% on Wildtype -XXXX% on variant -XXXX% overall (still dropping π) Only XXXX g/mL remained πͺ Keep that XXXX number in mind for later" [X Link](https://x.com/GeneInvesting/status/1970128079348801903) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-22T14:08Z 14.5K followers, 9260 engagements "Checking on my bet with @Biotech2k1 On 2/4/25 to today $NTLA $XXXX β‘ $XXXXX (+107.5%) $BBIO $XXXXX β‘ $XXXXX (+60.3%) Good start πͺ" [X Link](https://x.com/GeneInvesting/status/1974646332863496449) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-05T01:22Z 14.5K followers, 2419 engagements "Im predicting @davidrliu will be awarded a Nobel Prize on Monday or Wednesday $PRME $BEAM Keep an eye out π 11:30 CEST is 2:30am PT/5:30am ET" [X Link](https://x.com/GeneInvesting/status/1975025816682807548) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-06T02:30Z 14.5K followers, 16.3K engagements "2 for X Special π Bet with @Biotech2k1 On 2/4/25 to today (8 months) $NTLA $XXXX β‘ $XXXXX (+154.4%) $BBIO $XXXXX β‘ $XXXXX (+67.7%) Bet with @techinvestoor ( X months ago) $NTLA π° $XXXXX β‘ $XXXXX (+128.1%) $HIMS π° $XXXXX β‘ $XXXXX (+29.0%)" [X Link](https://x.com/GeneInvesting/status/1976016654237827286) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-08T20:07Z 14.5K followers, 6031 engagements "Just got muted and called a clown because I showed him our bet standings just like he did when he was up on X weeks ago π€¦π»β $NTLA $HIMS" [X Link](https://x.com/GeneInvesting/status/1976024532730454085) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-08T20:38Z 14.5K followers, 3471 engagements "Fundamentals in X snapshot $NTLA vs $BBIO π₯Ή @Biotech2k1" [X Link](https://x.com/GeneInvesting/status/1976338251758829619) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-09T17:25Z 14.5K followers, 3063 engagements "Big morning in gene editingβ 1) $CRSP unveiled what appears to be strong preclinical AATD data w/ their new gene correction tech obviously behind $BEAM and $PRME but puts extra pressure on BEAM to get significant rights to PRMEs program through arbitration imo 2) Beams spinoff for RNA editing Orbital was purchased for $1.5b by Bristol Myers Squibb 3) NTLA essentially confirmed HAE data will be Nov 6-10 (due to not stating data at the upcoming HAE event)" [X Link](https://x.com/GeneInvesting/status/1976647660347244569) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T13:55Z 14.5K followers, 4005 engagements "@StonkEddie What are you talking about Ive called $PRME my second favorite stock in the market at beginning of year. Prior to that $BEAM was my biggest position for years. Ive done complete deep dives on all X companies including $CRSP. Where have you been" [X Link](https://x.com/GeneInvesting/status/1976652491136921852) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T14:14Z 14.5K followers, XXX engagements "@Alex___VA $BEAM just got walloped by $CRSP and $PRME on AATD so the arbitration becomes extra important now" [X Link](https://x.com/GeneInvesting/status/1976676694925918338) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T15:50Z 14.5K followers, XXX engagements "Good post discussing $BEAM and how theyve brought in big money π° Im rooting for them but cant get myself to back AATD which I was positive on but now see many threats (. $PRME $CRSP Tessera and multiple RNA editing competitors) and Wave X SCD. My popcorn is ready for Prime vs Beam arbitration announcement in 1H next year. πΏ" [X Link](https://x.com/GeneInvesting/status/1976869295184658577) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-11T04:35Z 14.5K followers, 6190 engagements "Time for another Where We Stand in CRISPR Land $NTLA $BEAM $PRME $CRSP Rankings X Intellia (2-3x XX month potential) HAE and CM data in X weeks are HUGE FDA approval is only XXX years away for HAE (the next CRISPR approval) large CM trial could fully enroll in next XX months ex-US HAE deal for cash π° 2-3x by end of 2027. X Beam (2x possibly 3x if Casgevy wakes up etc) Orbital sale is huge. Someone predicted $270-$300m to Beam I predict some of this money gets used in Prime arbitration to expand their partnership more Wave X (chemo) SCD hinges on whether or not Casgevy starts selling better" [X Link](https://x.com/GeneInvesting/status/1977147407373943197) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-11T23:00Z 14.5K followers, 23.3K engagements "And this is why stop losses are a fools game in smid biotech. You know how many people probably sold Friday or after hours when $NTLA was down X% on no company specific news Closed AH essentially flat and market looks very green for Monday. But obviously Trump could tweet again and it all reverses π" [X Link](https://x.com/GeneInvesting/status/1977521166677070271) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-12T23:46Z 14.5K followers, 4725 engagements "Flashback When Bernstein came up with a $XX target by being most bullish on AATD and I said AATD should be counted as a zero for the company. $NTLA discontinued their AATD program (3001) TWO days later They also said Ph. X HAE trial will be different than Ph. X (untrue)" [X Link](https://x.com/GeneInvesting/status/1977574471184916505) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T03:17Z 14.5K followers, 3949 engagements "I was lucky and had the tab still open If you go to this page now it has disappeared. π€ $NTLA" [X Link](https://x.com/GeneInvesting/status/1977810335383040182) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T18:55Z 14.5K followers, 7031 engagements "One of the premier KOLs in the ATTR-CM space @MasriAhmadMD He and his hospital are part of Intellias Magnitude Ph. X study. $NTLA Interesting comments on payers and how combo therapy is actually possible today (yet doctors typically avoid this due to unproven benefit). This could completely change once Magnitude reads out. 12/18/24/30 months Mono Vutri: 1.20/1.24/1.29/1.30 Overall ALNY: 1.08/1.07/1.20/1.19 (60% mono/40% combo) Vutri+Taf: 0.90/0.82/1.06/1.03 (Combo calculated by me) Seems odd to me the XXXX to XXXX jump (I hand calculated this long ago so I might need to recheck it)." [X Link](https://x.com/GeneInvesting/status/1977868791683145828) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T22:47Z 14.5K followers, 2442 engagements "@Gabrielmendesnu Dont need any others if these X pan out. Hem B is milestones and small royalties and thats also in clinic through $REGN now" [X Link](https://x.com/GeneInvesting/status/1978121365061279817) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-14T15:30Z 14.5K followers, XXX engagements "The power of Jerome From -X% to +3.5% $NTLA" [X Link](https://x.com/GeneInvesting/status/1978162678834073768) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-14T18:15Z 14.5K followers, 3086 engagements "@GrzegorzPko Yes Ive seen that. Have no idea who would short it unless its hedging" [X Link](https://x.com/GeneInvesting/status/1979300804453704191) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T21:37Z 14.5K followers, XX engagements "Why so many CRISPR haters exist Most biotech investors have been burned by gene therapy at one point or another. $SGMO $BLUE $SRPT have all hurt the brokerage accounts of thousands of biotech investors. Those who have been around a long time have likely lost significant money in at least X of the X or one of the many other busts in gene therapy over the years. The few who havent been burned by gene therapy probably are invested in the chronic therapies of competitors. Why this time is different: in vivo LNP delivery no viral AAV delivery CRISPR gene therapy liver is easiest target π― one and" [X Link](https://x.com/GeneInvesting/status/1973723554442322056) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-02T12:15Z 14.5K followers, 12.9K engagements "Which CRISPR company will have MORE REVENUE each year 2026: $CRSP 2027: CRSP 2028: NTLA 2029: NTLA 2030: NTLA 2031: NTLA 2032: NTLA 2033: NTLA or BEAM 2034 $NTLA or $BEAM or $PRME 2035 NTLA or BEAM or PRME" [X Link](https://x.com/GeneInvesting/status/1974100037564240139) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-03T13:11Z 14.5K followers, 6139 engagements "People on X: Hey Anthony what is the best gene editing stock $BEAM $NTLA $CRSP $PRME" [X Link](https://x.com/GeneInvesting/status/1976452648397307981) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T01:00Z 14.5K followers, 3997 engagements "Trump is giving everyone on last chance on $NTLA $PRME I wouldnt touch unless under $5" [X Link](https://x.com/GeneInvesting/status/1976673704764727679) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T15:38Z 14.5K followers, 8644 engagements "@VEGA_n1 Yeah maybe this is why he hates on $NTLA He says he bought it after bubble but $XXX average at that point was still a bubble. I bought some shares too high also but I also bought before the run so I never had an average even close to that" [X Link](https://x.com/GeneInvesting/status/1976678924718670026) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T15:59Z 14.5K followers, XXX engagements "Very interesting that $NTLA isnt listed. Intellias website had this as an event for Tuesday yet when I checked yesterday it disappeared π€ Why would they decide to cancel it $CRSP $PRME $BEAM and many others are still listed" [X Link](https://x.com/GeneInvesting/status/1977478315436077476) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-12T20:55Z 14.5K followers, 13.3K engagements "Love seeing families stand up to people like Adam F. Patients and their families advocating can make a big difference $SRPT" [X Link](https://x.com/GeneInvesting/status/1977538202341925198) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T00:53Z 14.5K followers, 5441 engagements "The serum doesn't have a commercial name yetit's a research formulation from Schweitzer Biotech in Taiwan. Key ingredients: Centella asiatica extracts IGF-1 FGF-7 caffeine and vitamin B5. A study showed XX% hair density increase in XX days. More trials needed. -Grok" [X Link](https://x.com/GeneInvesting/status/1977554207717875797) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T01:57Z 14.5K followers, 3619 engagements "@allsugarzerota1 From this cool guy named Anthony aka Gene Investing. All data is accurate from the companies themselves. $ALNY had healthiest group of patients" [X Link](https://x.com/GeneInvesting/status/1977734619790295522) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T13:54Z 14.5K followers, XXX engagements "How are we supposed to go about our daily lives when $NTLA is so close to dropping TWO big data readouts" [X Link](https://x.com/GeneInvesting/status/1978303081897922973) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T03:33Z 14.5K followers, 5979 engagements "Baby KJ is looking STRONG πͺ Gene editing is the future of biotech $BEAM $PRME $NTLA $CRSP" [X Link](https://x.com/GeneInvesting/status/1978521271013879955) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T18:00Z 14.5K followers, 5494 engagements "The Mona Lisa of 1-month stock charts $NTLA Hang this in the Louvre π€ P.S. no one show the X year chart π₯Ή" [X Link](https://x.com/GeneInvesting/status/1978529294180614287) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T18:31Z 14.5K followers, 3319 engagements "@AlexHumphries25 Itll be interesting for sure" [X Link](https://x.com/GeneInvesting/status/1978532756507201748) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T18:45Z 14.5K followers, XXX engagements "@rptr_cap So if someone not saying me was all-in $NTLA would that make me King of the Degens Or is that for the Fartcoin people π€" [X Link](https://x.com/GeneInvesting/status/1978550789875384487) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T19:57Z 14.5K followers, XXX engagements "@rptr_cap Just a crap load of shares. X huge data readouts in XXX weeks will keep volatility high" [X Link](https://x.com/GeneInvesting/status/1978551953304002579) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T20:02Z 14.5K followers, XX engagements "@rptr_cap Id currently rank potential in next XX months as 1) $NTLA 2) $BEAM 3) $PRME 4) $CRSP" [X Link](https://x.com/GeneInvesting/status/1978552507442864483) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T20:04Z 14.5K followers, XXX engagements "@Dr_Singularity @DrFerdowsi Very cool π" [X Link](https://x.com/GeneInvesting/status/1978566920119996746) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-15T21:01Z 14.5K followers, XXX engagements "6 Not understanding PoS can be very different for different programs (ie oncology is notorious for having lowest genetic medicines soon will be well established as the highest)" [X Link](https://x.com/GeneInvesting/status/1978998811381952993) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T01:37Z 14.5K followers, 1751 engagements "@crisprspace @FDA CGD will probably get the RDEP" [X Link](https://x.com/GeneInvesting/status/1979041855879745563) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T04:28Z 14.5K followers, XXX engagements "Remind me which one the bears said should close their doors Looking forward to extending the bottom line in 25-28 days. $NTLA $ALNY $BBIO" [X Link](https://x.com/GeneInvesting/status/1977733416775778728) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-13T13:49Z 14.5K followers, 8200 engagements "Sold X $XX puts on $NTLA for tomorrow. Received $XX each. Lets see if I score a quick $XXX π€" [X Link](https://x.com/GeneInvesting/status/1978845959699218438) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-16T15:30Z 14.5K followers, 2275 engagements "Doctor to patient ATTR-PN conversation $NTLA $ALNY Doctor: Do you want a XX% chance to lower your nMIS+7 or a XXXX% chance Patient: XXXX% sounds better lets do that Doctor: Do you want to lower by XXX points on average or only XXXX points Patient: Is this a trick question Doctor: Do you want a XX% chance to worsen by XX points on average or a XXX% chance to worsen by XX Patient: Am I being punkd Doctor: Last question: do you want only X 2-4 hour treatment Or do you want X treatments per year Patient: Please tell me all of these good options are the same drug. Doctor: Youre in luck π" [X Link](https://x.com/GeneInvesting/status/1972104253708898438) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-28T01:01Z 14.5K followers, 16K engagements "Heres another fun example how sneaky $ALNY likes to be with their data See if you can spot the reason (on 2nd picture) their NT-proBNP looks way better than the reality of XXXX at XX months Comment below once you find it (I already did). $NTLA" [X Link](https://x.com/GeneInvesting/status/1972334842101780724) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-28T16:17Z 14.5K followers, 2546 engagements "So the $ALNY gen X drug finally started pivotal Ph. X. Up to X locations. Enrolling 1250 patients. Will be very key the gap between $NTLA approval and this approval. Ill assume 12-18+ month headstart on commercial for Intellia. Will be interesting if both go for interim analysis before XX months. Alnylam is again only taking 8500 on NT-proBNP and they estimated XX months with max of X years. Intellias pivotal takes 10000. Time frame is set at minimum of XX months up to XX months" [X Link](https://x.com/GeneInvesting/status/1972416188677599288) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-28T21:40Z 14.5K followers, 2513 engagements "Fascinating. $ALNY $BBIO $NTLA $PFE Key here is the baseline Tafamidis subgroup This shows Tafamidis (stabilizer) does not help with gastrointestinal events yet Vutrisiran (silencer) does in a major way. π" [X Link](https://x.com/GeneInvesting/status/1972742336062107913) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-29T19:16Z 14.5K followers, 2992 engagements "HAE Competitors- Data and Costπ² $NTLA $IONS $BCRX $PHVS $TAK X. Takhzyro π 13-26 injections per year lead HAE drug in world $1.54b (2024) XX% mean reduction (every X weeks) XX% mean reduction (every X weeks) COST π° $550k per year (2 week) X. Haegarda π 2x per week XXX per year MEDIAN reduction of XXXX% (60-1U) (Obviously median for NTLA is 100%) XX% (60-IU) had at least XX% reduction XX% (60-IU) had no attacks COST π°$537k per year X. Orladeyo π daily oral tablets XX% mean reduction COST π°$485k per year X. Garadacimab π XX injections per year FDA approved on June XX 2025 XXXX% mean" [X Link](https://x.com/GeneInvesting/status/1973004824661872794) [@GeneInvesting](/creator/x/GeneInvesting) 2025-09-30T12:39Z 14.5K followers, 10.6K engagements "I also need to dispel this notion that $NTLA isnt adding anything beyond what $ALNY has already achieved. Its simply not close to being true. Nt-proBNP for Vutri at 12m was XX% worse than baseline despite only XXX% Class III patients and XX% variant. It was only X% worse for Nex Z despite XX% Class III XX% variant and multiple patients with baselines well above the 8500 limit of BBIO and ALNY. Also for Class I/II which was XXXX% of ALNY Nex Z actually improved by 3%. Nex Z is highly differentiated versus Vutrisiran in ATTR PN and CM. For PN Nex Z had -XXX average improvement on nMIS+7 and" [X Link](https://x.com/GeneInvesting/status/1974609424972226821) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-04T22:55Z 14.5K followers, 3105 engagements "BEAST MODE ACTIVATED $NTLA If you have a love one who is a bear go check on them. They need our support π₯Ή $XX β $XX β $XX β $XX β This is a true @Maximus_Holla today" [X Link](https://x.com/GeneInvesting/status/1975945003701838057) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-08T15:22Z 14.5K followers, 6000 engagements "Im honestly worried about this man most of them rallied XXX% before I sold them. π€ π₯Ή XXX% is a 6x and I know of exactly ZERO of his stocks that he recently sold that went 6x from lows. He sold $NTLA at $XXXXX 2x from lows He sold $CRSP at $XXXXX barely above recent lows. $IPSC sale was likely XX% above lows $MGX at $XXXX was 2x from lows $PRME sale at $XXXX was 5x lows. So 4/5 of these didnt come close to his 6x statement. I wont even get into others like NVTA DNA etc" [X Link](https://x.com/GeneInvesting/status/1976669048126767443) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-10T15:20Z 14.5K followers, 2685 engagements "12 Reasons Why Intellia Therapeutics is My All-In π X. Three Phase X trials $NTLA has the only three in vivo CRISPR Ph. X trials in the world π X. In vivo higher margins π° much faster + easier administration π¨ 2-4 hour outpatient drip π§ X. LNP not AAV unlike previous gene therapy NTLA delivers with LNP not AAV (which is notorious for safety problems) β X. The next CRISPR FDA approval in XX months second: XX months after that third: XX months after that X. ATTR is a massive market $XX billion peak π HAE is slept on $5b market in 2028 X. Patients are lining up NTLA has already dosed 750" [X Link](https://x.com/GeneInvesting/status/1978149025108140226) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-14T17:20Z 14.5K followers, 9559 engagements "Yeah pretty hilarious when HAE companies are forced to buy the competition. $NTLA Ive been telling $BCRX holders to get out of that name ASAP -XXXX% today $ATXS +39%" [X Link](https://x.com/GeneInvesting/status/1978158580365684944) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-14T17:58Z 14.5K followers, 2905 engagements "$REGN is up to XX locations on their CRISPR Hemophilia B trial. Originally was 65%/35% in favor of REGN but $NTLA gave up their XX% because they didnt want the XX% cost. Intellia is still eligible for $XXX million in milestones and 8-15% royalties. Hem A remains 65%/35% (pre-clinical)" [X Link](https://x.com/GeneInvesting/status/1978821991667740890) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-16T13:55Z 14.5K followers, 3211 engagements "@RNAiAnalyst DM1 is $20b peak sales I agree ALNY has to buy something" [X Link](https://x.com/GeneInvesting/status/1978841783166492921) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-16T15:13Z 14.5K followers, XXX engagements "BREAKING NEWS π Here are the X FDA National Priority Vouchers: X Pergoveris for infertility X Teplizumab for Type I diabetes X Cytisinicline for nicotine vaping addiction X DB-OTO for deafness X Cenegermin-bkbj for blindness X RMC-6236 for pancreatic cancer X Bitopertin for porphyria X Ketamine for domestic manufacturing of a critical drug for general anesthesia 9Augmentin XR for domestic manufacturing of a common antibiotic Each recipient will receive a decision in 1-2 months following filing a complete application. Disappointing to not see any gene editing in this round. Although X is more" [X Link](https://x.com/GeneInvesting/status/1978953414399885313) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-16T22:37Z 14.5K followers, 7098 engagements "7 Incidence vs. Prevalence (TAM) Incidence: amount of new cases each year Prevalence: total number of cases (new and already existing) Ex: HAE vs. ATTR - HAE is less common (7500 in US) and typically diagnosed much earlier in life (20s or younger). - ATTR is highly under-diagnosed yet bigger already. But many patients arent diagnosed until 60s-80s. - this major age difference leads to a very different TAM opportunity as 10000-20000+ new ATTR patients could be found every year compared to only 100-150 HAE" [X Link](https://x.com/GeneInvesting/status/1979164044989993382) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T12:34Z 14.5K followers, XXX engagements "Oil Collapsing β Rates under X% β $XBI and $ARKG rising from the dead like a phoenixπ¦π₯β Quantitative Tightening is over β Tons of money on sidelines β More rate cuts are coming β I TOLD YOU TO NOT BE SHORT BIOTECH π€" [X Link](https://x.com/GeneInvesting/status/1979207764997214302) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T15:27Z 14.5K followers, 2043 engagements "@jwhat X big data readouts in X weeks" [X Link](https://x.com/GeneInvesting/status/1979226031006584911) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-17T16:40Z 14.5K followers, XXX engagements "DAMN Im on FIRE π₯ $NTLA Now I can also guarantee the date and time for ATTR-CM data π Monday November 10th in New Orleans at 2:17pm (Central Time). In summary: Saturday Nov. X @ 5:13pm ET (HAE data) Monday Nov. XX @ 2:17pm CT (ATTR)" [X Link](https://x.com/GeneInvesting/status/1979376480116445300) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-18T02:38Z 14.5K followers, 4275 engagements "@BiopharmIQ Nice shoutout for $NTLA I just posted the dates for the X big data announcements before the company has announced. X weeks away" [X Link](https://x.com/GeneInvesting/status/1979546861645213731) [@GeneInvesting](/creator/x/GeneInvesting) 2025-10-18T13:55Z 14.5K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@GeneInvesting
"And lets remember Intellias Class I/II would literally be off this graph Comparing $ALNY to $NTLA at 12m is like comparing prime Lebron James to Bronny. Heres the best part: XXXX% of Alnylam patients were Class I/II and they still had worsening of XX% on average at XX months. Intellias Class I/II π° XXXX (3% improvement) And Intellia had one Class X who was variant and baseline 19600+ (the other companies had 8500 max). They died at Day XXX so its likely the XXXX wouldve been even better without them"
X Link @GeneInvesting 2025-10-14T15:03Z 14.5K followers, 4877 engagements
"1 wasnt enough doctors say: lets cure X this time πͺ $BEAM $PRME $NTLA $CRSP The Gene Editing revolution has BEGUN"
X Link @GeneInvesting 2025-10-16T14:20Z 14.5K followers, 8637 engagements
"@3primeAnalytica He sold recently so he supposedly doesnt own it anymore. His new baby is $BBIO which is a direct competitor so thats why he shits on $NTLA. Its just remarkable how much misinformation I find from him"
X Link @GeneInvesting 2025-09-09T02:12Z 14.5K followers, XXX engagements
"$PFE alone made $XXX billion last year in ATTR-CM. They made $XXX billion in the first half of 2025. So even if that just stays equal and doesnt grow theyll be at $XXX billion this year plus the 1400 patients $ALNY treated in their first XX days plus the strong $BBIO start. Likely $X billion this year"
X Link @GeneInvesting 2025-09-12T17:22Z 14.5K followers, XXX engagements
"4) Grok expert mode also selected $NTLA over $BBIO and $ALNY β
ChatGPT first tried to use 36/42 month ALNY data to compare so that had to be corrected. Grok for some reason couldnt find NTLAs KCCQ value at first and was using inaccurate nt-probnp values for bbio and alny"
X Link @GeneInvesting 2025-09-13T00:28Z 14.5K followers, 1528 engagements
"This is beautiful I think tears of pride came to my eyes π₯Ήπ
$NTLA"
X Link @GeneInvesting 2025-09-17T02:54Z 14.5K followers, 5800 engagements
"@RandomBioThinks @SnackBioTech Definitely not the same. $BBIO will not equal $NTLA or gen X $ALNY in future"
X Link @GeneInvesting 2025-09-17T02:57Z 14.5K followers, XXX engagements
"@zhaoweiasu @ArkadiBaudelair We do know. Weve studied it for well over XX years"
X Link @GeneInvesting 2025-09-19T12:27Z 14.5K followers, XXX engagements
"Im XX% certain that these analysts are counting Gen X as Amvuttra too because there is ZERO chance Amvuttra EVER makes $9.2B in a year. $ALNY $NTLA I can see their Gen X (Nucresiran) making that though. In X weeks Intellia will essentially show that doctors will morally be unable to prescribe Amvuttra (once Nex Z is available). Ex: Do you want to worsen by XX% in your first year or not And Alnylam got their data with the healthiest group of patients by far (Hurt them on curves but helped them on majority of other things)"
X Link @GeneInvesting 2025-09-20T01:10Z 14.5K followers, 6905 engagements
"1/π§΅Why Nex Z is dramatically better than Vutrisiran $NTLA $ALNY $BBIO Nex Z: Day 28: -XX% (18.9 g/mL remained) XX month: -XXXX% on Wildtype -XXXX% on variant -XXXX% overall (still dropping π) Only XXXX g/mL remained πͺ Keep that XXXX number in mind for later"
X Link @GeneInvesting 2025-09-22T14:08Z 14.5K followers, 9260 engagements
"Checking on my bet with @Biotech2k1 On 2/4/25 to today $NTLA $XXXX β‘ $XXXXX (+107.5%) $BBIO $XXXXX β‘ $XXXXX (+60.3%) Good start πͺ"
X Link @GeneInvesting 2025-10-05T01:22Z 14.5K followers, 2419 engagements
"Im predicting @davidrliu will be awarded a Nobel Prize on Monday or Wednesday $PRME $BEAM Keep an eye out π 11:30 CEST is 2:30am PT/5:30am ET"
X Link @GeneInvesting 2025-10-06T02:30Z 14.5K followers, 16.3K engagements
"2 for X Special π Bet with @Biotech2k1 On 2/4/25 to today (8 months) $NTLA $XXXX β‘ $XXXXX (+154.4%) $BBIO $XXXXX β‘ $XXXXX (+67.7%) Bet with @techinvestoor ( X months ago) $NTLA π° $XXXXX β‘ $XXXXX (+128.1%) $HIMS π° $XXXXX β‘ $XXXXX (+29.0%)"
X Link @GeneInvesting 2025-10-08T20:07Z 14.5K followers, 6031 engagements
"Just got muted and called a clown because I showed him our bet standings just like he did when he was up on X weeks ago π€¦π»β $NTLA $HIMS"
X Link @GeneInvesting 2025-10-08T20:38Z 14.5K followers, 3471 engagements
"Fundamentals in X snapshot $NTLA vs $BBIO π₯Ή @Biotech2k1"
X Link @GeneInvesting 2025-10-09T17:25Z 14.5K followers, 3063 engagements
"Big morning in gene editingβ 1) $CRSP unveiled what appears to be strong preclinical AATD data w/ their new gene correction tech obviously behind $BEAM and $PRME but puts extra pressure on BEAM to get significant rights to PRMEs program through arbitration imo 2) Beams spinoff for RNA editing Orbital was purchased for $1.5b by Bristol Myers Squibb 3) NTLA essentially confirmed HAE data will be Nov 6-10 (due to not stating data at the upcoming HAE event)"
X Link @GeneInvesting 2025-10-10T13:55Z 14.5K followers, 4005 engagements
"@StonkEddie What are you talking about Ive called $PRME my second favorite stock in the market at beginning of year. Prior to that $BEAM was my biggest position for years. Ive done complete deep dives on all X companies including $CRSP. Where have you been"
X Link @GeneInvesting 2025-10-10T14:14Z 14.5K followers, XXX engagements
"@Alex___VA $BEAM just got walloped by $CRSP and $PRME on AATD so the arbitration becomes extra important now"
X Link @GeneInvesting 2025-10-10T15:50Z 14.5K followers, XXX engagements
"Good post discussing $BEAM and how theyve brought in big money π° Im rooting for them but cant get myself to back AATD which I was positive on but now see many threats (. $PRME $CRSP Tessera and multiple RNA editing competitors) and Wave X SCD. My popcorn is ready for Prime vs Beam arbitration announcement in 1H next year. πΏ"
X Link @GeneInvesting 2025-10-11T04:35Z 14.5K followers, 6190 engagements
"Time for another Where We Stand in CRISPR Land $NTLA $BEAM $PRME $CRSP Rankings X Intellia (2-3x XX month potential) HAE and CM data in X weeks are HUGE FDA approval is only XXX years away for HAE (the next CRISPR approval) large CM trial could fully enroll in next XX months ex-US HAE deal for cash π° 2-3x by end of 2027. X Beam (2x possibly 3x if Casgevy wakes up etc) Orbital sale is huge. Someone predicted $270-$300m to Beam I predict some of this money gets used in Prime arbitration to expand their partnership more Wave X (chemo) SCD hinges on whether or not Casgevy starts selling better"
X Link @GeneInvesting 2025-10-11T23:00Z 14.5K followers, 23.3K engagements
"And this is why stop losses are a fools game in smid biotech. You know how many people probably sold Friday or after hours when $NTLA was down X% on no company specific news Closed AH essentially flat and market looks very green for Monday. But obviously Trump could tweet again and it all reverses π"
X Link @GeneInvesting 2025-10-12T23:46Z 14.5K followers, 4725 engagements
"Flashback When Bernstein came up with a $XX target by being most bullish on AATD and I said AATD should be counted as a zero for the company. $NTLA discontinued their AATD program (3001) TWO days later They also said Ph. X HAE trial will be different than Ph. X (untrue)"
X Link @GeneInvesting 2025-10-13T03:17Z 14.5K followers, 3949 engagements
"I was lucky and had the tab still open If you go to this page now it has disappeared. π€ $NTLA"
X Link @GeneInvesting 2025-10-13T18:55Z 14.5K followers, 7031 engagements
"One of the premier KOLs in the ATTR-CM space @MasriAhmadMD He and his hospital are part of Intellias Magnitude Ph. X study. $NTLA Interesting comments on payers and how combo therapy is actually possible today (yet doctors typically avoid this due to unproven benefit). This could completely change once Magnitude reads out. 12/18/24/30 months Mono Vutri: 1.20/1.24/1.29/1.30 Overall ALNY: 1.08/1.07/1.20/1.19 (60% mono/40% combo) Vutri+Taf: 0.90/0.82/1.06/1.03 (Combo calculated by me) Seems odd to me the XXXX to XXXX jump (I hand calculated this long ago so I might need to recheck it)."
X Link @GeneInvesting 2025-10-13T22:47Z 14.5K followers, 2442 engagements
"@Gabrielmendesnu Dont need any others if these X pan out. Hem B is milestones and small royalties and thats also in clinic through $REGN now"
X Link @GeneInvesting 2025-10-14T15:30Z 14.5K followers, XXX engagements
"The power of Jerome From -X% to +3.5% $NTLA"
X Link @GeneInvesting 2025-10-14T18:15Z 14.5K followers, 3086 engagements
"@GrzegorzPko Yes Ive seen that. Have no idea who would short it unless its hedging"
X Link @GeneInvesting 2025-10-17T21:37Z 14.5K followers, XX engagements
"Why so many CRISPR haters exist Most biotech investors have been burned by gene therapy at one point or another. $SGMO $BLUE $SRPT have all hurt the brokerage accounts of thousands of biotech investors. Those who have been around a long time have likely lost significant money in at least X of the X or one of the many other busts in gene therapy over the years. The few who havent been burned by gene therapy probably are invested in the chronic therapies of competitors. Why this time is different: in vivo LNP delivery no viral AAV delivery CRISPR gene therapy liver is easiest target π― one and"
X Link @GeneInvesting 2025-10-02T12:15Z 14.5K followers, 12.9K engagements
"Which CRISPR company will have MORE REVENUE each year 2026: $CRSP 2027: CRSP 2028: NTLA 2029: NTLA 2030: NTLA 2031: NTLA 2032: NTLA 2033: NTLA or BEAM 2034 $NTLA or $BEAM or $PRME 2035 NTLA or BEAM or PRME"
X Link @GeneInvesting 2025-10-03T13:11Z 14.5K followers, 6139 engagements
"People on X: Hey Anthony what is the best gene editing stock $BEAM $NTLA $CRSP $PRME"
X Link @GeneInvesting 2025-10-10T01:00Z 14.5K followers, 3997 engagements
"Trump is giving everyone on last chance on $NTLA $PRME I wouldnt touch unless under $5"
X Link @GeneInvesting 2025-10-10T15:38Z 14.5K followers, 8644 engagements
"@VEGA_n1 Yeah maybe this is why he hates on $NTLA He says he bought it after bubble but $XXX average at that point was still a bubble. I bought some shares too high also but I also bought before the run so I never had an average even close to that"
X Link @GeneInvesting 2025-10-10T15:59Z 14.5K followers, XXX engagements
"Very interesting that $NTLA isnt listed. Intellias website had this as an event for Tuesday yet when I checked yesterday it disappeared π€ Why would they decide to cancel it $CRSP $PRME $BEAM and many others are still listed"
X Link @GeneInvesting 2025-10-12T20:55Z 14.5K followers, 13.3K engagements
"Love seeing families stand up to people like Adam F. Patients and their families advocating can make a big difference $SRPT"
X Link @GeneInvesting 2025-10-13T00:53Z 14.5K followers, 5441 engagements
"The serum doesn't have a commercial name yetit's a research formulation from Schweitzer Biotech in Taiwan. Key ingredients: Centella asiatica extracts IGF-1 FGF-7 caffeine and vitamin B5. A study showed XX% hair density increase in XX days. More trials needed. -Grok"
X Link @GeneInvesting 2025-10-13T01:57Z 14.5K followers, 3619 engagements
"@allsugarzerota1 From this cool guy named Anthony aka Gene Investing. All data is accurate from the companies themselves. $ALNY had healthiest group of patients"
X Link @GeneInvesting 2025-10-13T13:54Z 14.5K followers, XXX engagements
"How are we supposed to go about our daily lives when $NTLA is so close to dropping TWO big data readouts"
X Link @GeneInvesting 2025-10-15T03:33Z 14.5K followers, 5979 engagements
"Baby KJ is looking STRONG πͺ Gene editing is the future of biotech $BEAM $PRME $NTLA $CRSP"
X Link @GeneInvesting 2025-10-15T18:00Z 14.5K followers, 5494 engagements
"The Mona Lisa of 1-month stock charts $NTLA Hang this in the Louvre π€ P.S. no one show the X year chart π₯Ή"
X Link @GeneInvesting 2025-10-15T18:31Z 14.5K followers, 3319 engagements
"@AlexHumphries25 Itll be interesting for sure"
X Link @GeneInvesting 2025-10-15T18:45Z 14.5K followers, XXX engagements
"@rptr_cap So if someone not saying me was all-in $NTLA would that make me King of the Degens Or is that for the Fartcoin people π€"
X Link @GeneInvesting 2025-10-15T19:57Z 14.5K followers, XXX engagements
"@rptr_cap Just a crap load of shares. X huge data readouts in XXX weeks will keep volatility high"
X Link @GeneInvesting 2025-10-15T20:02Z 14.5K followers, XX engagements
"@rptr_cap Id currently rank potential in next XX months as 1) $NTLA 2) $BEAM 3) $PRME 4) $CRSP"
X Link @GeneInvesting 2025-10-15T20:04Z 14.5K followers, XXX engagements
"@Dr_Singularity @DrFerdowsi Very cool π"
X Link @GeneInvesting 2025-10-15T21:01Z 14.5K followers, XXX engagements
"6 Not understanding PoS can be very different for different programs (ie oncology is notorious for having lowest genetic medicines soon will be well established as the highest)"
X Link @GeneInvesting 2025-10-17T01:37Z 14.5K followers, 1751 engagements
"@crisprspace @FDA CGD will probably get the RDEP"
X Link @GeneInvesting 2025-10-17T04:28Z 14.5K followers, XXX engagements
"Remind me which one the bears said should close their doors Looking forward to extending the bottom line in 25-28 days. $NTLA $ALNY $BBIO"
X Link @GeneInvesting 2025-10-13T13:49Z 14.5K followers, 8200 engagements
"Sold X $XX puts on $NTLA for tomorrow. Received $XX each. Lets see if I score a quick $XXX π€"
X Link @GeneInvesting 2025-10-16T15:30Z 14.5K followers, 2275 engagements
"Doctor to patient ATTR-PN conversation $NTLA $ALNY Doctor: Do you want a XX% chance to lower your nMIS+7 or a XXXX% chance Patient: XXXX% sounds better lets do that Doctor: Do you want to lower by XXX points on average or only XXXX points Patient: Is this a trick question Doctor: Do you want a XX% chance to worsen by XX points on average or a XXX% chance to worsen by XX Patient: Am I being punkd Doctor: Last question: do you want only X 2-4 hour treatment Or do you want X treatments per year Patient: Please tell me all of these good options are the same drug. Doctor: Youre in luck π"
X Link @GeneInvesting 2025-09-28T01:01Z 14.5K followers, 16K engagements
"Heres another fun example how sneaky $ALNY likes to be with their data See if you can spot the reason (on 2nd picture) their NT-proBNP looks way better than the reality of XXXX at XX months Comment below once you find it (I already did). $NTLA"
X Link @GeneInvesting 2025-09-28T16:17Z 14.5K followers, 2546 engagements
"So the $ALNY gen X drug finally started pivotal Ph. X. Up to X locations. Enrolling 1250 patients. Will be very key the gap between $NTLA approval and this approval. Ill assume 12-18+ month headstart on commercial for Intellia. Will be interesting if both go for interim analysis before XX months. Alnylam is again only taking 8500 on NT-proBNP and they estimated XX months with max of X years. Intellias pivotal takes 10000. Time frame is set at minimum of XX months up to XX months"
X Link @GeneInvesting 2025-09-28T21:40Z 14.5K followers, 2513 engagements
"Fascinating. $ALNY $BBIO $NTLA $PFE Key here is the baseline Tafamidis subgroup This shows Tafamidis (stabilizer) does not help with gastrointestinal events yet Vutrisiran (silencer) does in a major way. π"
X Link @GeneInvesting 2025-09-29T19:16Z 14.5K followers, 2992 engagements
"HAE Competitors- Data and Costπ² $NTLA $IONS $BCRX $PHVS $TAK X. Takhzyro π 13-26 injections per year lead HAE drug in world $1.54b (2024) XX% mean reduction (every X weeks) XX% mean reduction (every X weeks) COST π° $550k per year (2 week) X. Haegarda π 2x per week XXX per year MEDIAN reduction of XXXX% (60-1U) (Obviously median for NTLA is 100%) XX% (60-IU) had at least XX% reduction XX% (60-IU) had no attacks COST π°$537k per year X. Orladeyo π daily oral tablets XX% mean reduction COST π°$485k per year X. Garadacimab π XX injections per year FDA approved on June XX 2025 XXXX% mean"
X Link @GeneInvesting 2025-09-30T12:39Z 14.5K followers, 10.6K engagements
"I also need to dispel this notion that $NTLA isnt adding anything beyond what $ALNY has already achieved. Its simply not close to being true. Nt-proBNP for Vutri at 12m was XX% worse than baseline despite only XXX% Class III patients and XX% variant. It was only X% worse for Nex Z despite XX% Class III XX% variant and multiple patients with baselines well above the 8500 limit of BBIO and ALNY. Also for Class I/II which was XXXX% of ALNY Nex Z actually improved by 3%. Nex Z is highly differentiated versus Vutrisiran in ATTR PN and CM. For PN Nex Z had -XXX average improvement on nMIS+7 and"
X Link @GeneInvesting 2025-10-04T22:55Z 14.5K followers, 3105 engagements
"BEAST MODE ACTIVATED $NTLA If you have a love one who is a bear go check on them. They need our support π₯Ή $XX β
$XX β
$XX β
$XX β
This is a true @Maximus_Holla today"
X Link @GeneInvesting 2025-10-08T15:22Z 14.5K followers, 6000 engagements
"Im honestly worried about this man most of them rallied XXX% before I sold them. π€ π₯Ή XXX% is a 6x and I know of exactly ZERO of his stocks that he recently sold that went 6x from lows. He sold $NTLA at $XXXXX 2x from lows He sold $CRSP at $XXXXX barely above recent lows. $IPSC sale was likely XX% above lows $MGX at $XXXX was 2x from lows $PRME sale at $XXXX was 5x lows. So 4/5 of these didnt come close to his 6x statement. I wont even get into others like NVTA DNA etc"
X Link @GeneInvesting 2025-10-10T15:20Z 14.5K followers, 2685 engagements
"12 Reasons Why Intellia Therapeutics is My All-In π X. Three Phase X trials $NTLA has the only three in vivo CRISPR Ph. X trials in the world π X. In vivo higher margins π° much faster + easier administration π¨ 2-4 hour outpatient drip π§ X. LNP not AAV unlike previous gene therapy NTLA delivers with LNP not AAV (which is notorious for safety problems) β X. The next CRISPR FDA approval in XX months second: XX months after that third: XX months after that X. ATTR is a massive market $XX billion peak π HAE is slept on $5b market in 2028 X. Patients are lining up NTLA has already dosed 750"
X Link @GeneInvesting 2025-10-14T17:20Z 14.5K followers, 9559 engagements
"Yeah pretty hilarious when HAE companies are forced to buy the competition. $NTLA Ive been telling $BCRX holders to get out of that name ASAP -XXXX% today $ATXS +39%"
X Link @GeneInvesting 2025-10-14T17:58Z 14.5K followers, 2905 engagements
"$REGN is up to XX locations on their CRISPR Hemophilia B trial. Originally was 65%/35% in favor of REGN but $NTLA gave up their XX% because they didnt want the XX% cost. Intellia is still eligible for $XXX million in milestones and 8-15% royalties. Hem A remains 65%/35% (pre-clinical)"
X Link @GeneInvesting 2025-10-16T13:55Z 14.5K followers, 3211 engagements
"@RNAiAnalyst DM1 is $20b peak sales I agree ALNY has to buy something"
X Link @GeneInvesting 2025-10-16T15:13Z 14.5K followers, XXX engagements
"BREAKING NEWS π Here are the X FDA National Priority Vouchers: X Pergoveris for infertility X Teplizumab for Type I diabetes X Cytisinicline for nicotine vaping addiction X DB-OTO for deafness X Cenegermin-bkbj for blindness X RMC-6236 for pancreatic cancer X Bitopertin for porphyria X Ketamine for domestic manufacturing of a critical drug for general anesthesia 9Augmentin XR for domestic manufacturing of a common antibiotic Each recipient will receive a decision in 1-2 months following filing a complete application. Disappointing to not see any gene editing in this round. Although X is more"
X Link @GeneInvesting 2025-10-16T22:37Z 14.5K followers, 7098 engagements
"7 Incidence vs. Prevalence (TAM) Incidence: amount of new cases each year Prevalence: total number of cases (new and already existing) Ex: HAE vs. ATTR - HAE is less common (7500 in US) and typically diagnosed much earlier in life (20s or younger). - ATTR is highly under-diagnosed yet bigger already. But many patients arent diagnosed until 60s-80s. - this major age difference leads to a very different TAM opportunity as 10000-20000+ new ATTR patients could be found every year compared to only 100-150 HAE"
X Link @GeneInvesting 2025-10-17T12:34Z 14.5K followers, XXX engagements
"Oil Collapsing β
Rates under X% β
$XBI and $ARKG rising from the dead like a phoenixπ¦π₯β
Quantitative Tightening is over β
Tons of money on sidelines β
More rate cuts are coming β
I TOLD YOU TO NOT BE SHORT BIOTECH π€"
X Link @GeneInvesting 2025-10-17T15:27Z 14.5K followers, 2043 engagements
"@jwhat X big data readouts in X weeks"
X Link @GeneInvesting 2025-10-17T16:40Z 14.5K followers, XXX engagements
"DAMN Im on FIRE π₯ $NTLA Now I can also guarantee the date and time for ATTR-CM data π Monday November 10th in New Orleans at 2:17pm (Central Time). In summary: Saturday Nov. X @ 5:13pm ET (HAE data) Monday Nov. XX @ 2:17pm CT (ATTR)"
X Link @GeneInvesting 2025-10-18T02:38Z 14.5K followers, 4275 engagements
"@BiopharmIQ Nice shoutout for $NTLA I just posted the dates for the X big data announcements before the company has announced. X weeks away"
X Link @GeneInvesting 2025-10-18T13:55Z 14.5K followers, XXX engagements
/creator/twitter::1246632233579896833/posts